1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of FOXA1 mRNA CTD PMID:32387197 17beta-estradiol multiple interactions ISO RGD:1605727 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of FOXA1 mRNA more ... CTD PMID:21151129 more ... 17beta-estradiol decreases expression ISO RGD:1605727 6480464 Estradiol results in decreased expression of FOXA1 mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:10718 6480464 Estradiol results in increased expression of FOXA1 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1605727 6480464 Estradiol results in increased expression of FOXA1 mRNA CTD PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:1605727 6480464 Curcumin inhibits the reaction [Dihydrotestosterone promotes the reaction [FOXA1 protein binds to KLK3 enhancer]] more ... CTD PMID:22258452 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10718 6480464 Tetrachlorodibenzodioxin affects the expression of FOXA1 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1605727 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXA1 mRNA CTD PMID:21632981 , PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO RGD:1605727 6480464 FOXA1 protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:22596188 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1605727 6480464 FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]] more ... CTD PMID:22596188 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXA1 mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FOXA1 mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 4,4'-sulfonyldiphenol increases expression ISO RGD:10718 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FOXA1 mRNA CTD PMID:30951980 , PMID:33297965 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1605727 6480464 [Decitabine co-treated with trichostatin A] results in decreased expression of FOXA1 mRNA CTD PMID:17891453 9-cis-retinoic acid increases expression ISO RGD:1605727 6480464 Alitretinoin results in increased expression of FOXA1 mRNA CTD PMID:17034753 aflatoxin B1 decreases expression ISO RGD:1605727 6480464 Aflatoxin B1 results in decreased expression of FOXA1 mRNA CTD PMID:22100608 aflatoxin B1 increases methylation ISO RGD:1605727 6480464 Aflatoxin B1 results in increased methylation of FOXA1 exon CTD PMID:30157460 all-trans-4-oxoretinoic acid increases expression ISO RGD:1605727 6480464 4-oxoretinoic acid results in increased expression of FOXA1 mRNA CTD PMID:17034753 all-trans-4-oxoretinol increases expression ISO RGD:1605727 6480464 4-oxoretinol results in increased expression of FOXA1 mRNA CTD PMID:17034753 all-trans-retinoic acid multiple interactions ISO RGD:1605727 6480464 [4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of FOXA1 mRNA] CTD PMID:31711903 all-trans-retinoic acid decreases expression ISO RGD:10718 6480464 Tretinoin results in decreased expression of FOXA1 mRNA CTD PMID:34942354 all-trans-retinoic acid affects expression ISO RGD:1605727 6480464 Tretinoin affects the expression of FOXA1 mRNA CTD PMID:31600526 all-trans-retinoic acid increases expression ISO RGD:1605727 6480464 Tretinoin results in increased expression of FOXA1 mRNA CTD PMID:17034753 , PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:10718 6480464 Tretinoin results in increased expression of FOXA1 mRNA CTD PMID:16604517 all-trans-retinol increases expression ISO RGD:1605727 6480464 Vitamin A results in increased expression of FOXA1 mRNA CTD PMID:17034753 amiodarone decreases expression ISO RGD:1605727 6480464 Amiodarone results in decreased expression of FOXA1 mRNA CTD PMID:27089845 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FOXA1 mRNA CTD PMID:16483693 arsane multiple interactions ISO RGD:1605727 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FOXA1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1605727 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FOXA1 mRNA CTD PMID:32525701 arsenite(3-) decreases expression ISO RGD:1605727 6480464 arsenite results in decreased expression of FOXA1 mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:1605727 6480464 arsenite inhibits the reaction [G3BP1 protein binds to FOXA1 mRNA], Fulvestrant inhibits the reaction [arsenite results in decreased expression of FOXA1 mRNA] CTD PMID:31646340 , PMID:32406909 arsenous acid affects methylation ISO RGD:1605727 6480464 Arsenic Trioxide affects the methylation of FOXA1 promoter CTD PMID:26046465 arsenous acid multiple interactions ISO RGD:1605727 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of FOXA1 mRNA CTD PMID:25913414 azathioprine decreases expression ISO RGD:1605727 6480464 Azathioprine results in decreased expression of FOXA1 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:10718 6480464 Benzo(a)pyrene results in increased expression of FOXA1 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of FOXA1 mRNA CTD PMID:34283317 benzo[a]pyrene decreases expression ISO RGD:1605727 6480464 Benzo(a)pyrene results in decreased expression of FOXA1 mRNA CTD PMID:26238291 , PMID:27221058 benzo[a]pyrene increases expression ISO RGD:1605727 6480464 Benzo(a)pyrene results in increased expression of FOXA1 mRNA, Benzo(a)pyrene results in increased expression of FOXA1 protein CTD PMID:32717239 benzo[a]pyrene decreases expression ISO RGD:10718 6480464 Benzo(a)pyrene results in decreased expression of FOXA1 mRNA CTD PMID:22228805 benzo[b]fluoranthene decreases expression ISO RGD:10718 6480464 benzo(b)fluoranthene results in decreased expression of FOXA1 mRNA CTD PMID:26377693 beta-carotene increases expression ISO RGD:1605727 6480464 beta Carotene results in increased expression of FOXA1 mRNA CTD PMID:17034753 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of FOXA1 mRNA CTD PMID:16648578 bis(2-chloroethyl) sulfide increases expression ISO RGD:10718 6480464 Mustard Gas results in increased expression of FOXA1 mRNA CTD PMID:15674844 bisphenol A multiple interactions ISO RGD:1605727 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in decreased expression of FOXA1 protein] more ... CTD PMID:26363213 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FOXA1 mRNA CTD PMID:31697385 , PMID:32145629 bisphenol A increases expression ISO RGD:10718 6480464 bisphenol A results in increased expression of FOXA1 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FOXA1 gene CTD PMID:28505145 bisphenol A affects methylation ISO RGD:10718 6480464 bisphenol A affects the methylation of FOXA1 promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FOXA1 mRNA, bisphenol A results in decreased expression of FOXA1 protein CTD PMID:25181051 , PMID:29643838 bisphenol A decreases expression ISO RGD:1605727 6480464 bisphenol A results in decreased expression of FOXA1 mRNA, bisphenol A results in decreased expression of FOXA1 protein CTD PMID:26363213 bisphenol F increases expression ISO RGD:10718 6480464 bisphenol F results in increased expression of FOXA1 mRNA CTD PMID:30951980 bortezomib multiple interactions ISO RGD:1605727 6480464 [arsenic trioxide co-treated with Bortezomib] results in increased expression of FOXA1 mRNA CTD PMID:25913414 bortezomib decreases expression ISO RGD:1605727 6480464 Bortezomib results in decreased expression of FOXA1 mRNA CTD PMID:20471514 buta-1,3-diene decreases expression ISO RGD:10718 6480464 1, 3-butadiene results in decreased expression of FOXA1 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:1605727 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FOXA1 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1605727 6480464 butyraldehyde results in decreased expression of FOXA1 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1605727 6480464 Cadmium results in increased expression of FOXA1 mRNA CTD PMID:31646340 cadmium atom multiple interactions ISO RGD:1605727 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXA1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1605727 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXA1 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:1605727 6480464 Caffeine results in decreased phosphorylation of FOXA1 protein CTD PMID:35688186 capsaicin decreases expression ISO RGD:1605727 6480464 Capsaicin results in decreased expression of FOXA1 mRNA CTD PMID:18533110 carbamazepine affects expression ISO RGD:1605727 6480464 Carbamazepine affects the expression of FOXA1 mRNA CTD PMID:24752500 , PMID:25979313 carbamazepine affects expression ISO RGD:10718 6480464 Carbamazepine affects the expression of FOXA1 mRNA CTD PMID:22634333 carbon nanotube decreases expression ISO RGD:1605727 6480464 Nanotubes, Carbon results in decreased expression of FOXA1 mRNA CTD PMID:23634900 carbon nanotube decreases expression ISO RGD:10718 6480464 Nanotubes, Carbon analog results in decreased expression of FOXA1 mRNA CTD PMID:25554681 CHIR 99021 increases expression ISO RGD:1605727 6480464 Chir 99021 results in increased expression of FOXA1 mRNA CTD PMID:31711903 CHIR 99021 multiple interactions ISO RGD:1605727 6480464 4-(5-benzo(1 more ... CTD PMID:31711903 chlorpyrifos decreases expression ISO RGD:10718 6480464 Chlorpyrifos results in decreased expression of FOXA1 mRNA CTD PMID:37019170 choline affects expression ISO RGD:1605727 6480464 Choline affects the expression of FOXA1 mRNA CTD PMID:17616785 choline multiple interactions ISO RGD:10718 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXA1 gene more ... CTD PMID:20938992 , PMID:25712622 choline multiple interactions ISO RGD:1605727 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FOXA1 mRNA] more ... CTD PMID:25712622 copper(II) sulfate decreases expression ISO RGD:1605727 6480464 Copper Sulfate results in decreased expression of FOXA1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1605727 6480464 coumarin results in decreased phosphorylation of FOXA1 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:10718 6480464 Asbestos, Crocidolite results in decreased expression of FOXA1 mRNA CTD PMID:29279043 curcumin multiple interactions ISO RGD:1605727 6480464 Curcumin inhibits the reaction [Dihydrotestosterone promotes the reaction [FOXA1 protein binds to KLK3 enhancer]], Curcumin inhibits the reaction [Dihydrotestosterone promotes the reaction [FOXA1 protein binds to TMPRSS2 enhancer]] CTD PMID:22258452 cyclosporin A decreases expression ISO RGD:1605727 6480464 Cyclosporine results in decreased expression of FOXA1 mRNA CTD PMID:20106945 , PMID:27989131 diarsenic trioxide affects methylation ISO RGD:1605727 6480464 Arsenic Trioxide affects the methylation of FOXA1 promoter CTD PMID:26046465 diarsenic trioxide multiple interactions ISO RGD:1605727 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of FOXA1 mRNA CTD PMID:25913414 dichloromethane decreases expression ISO RGD:10718 6480464 Methylene Chloride results in decreased expression of FOXA1 mRNA CTD PMID:28392392 diclofenac affects expression ISO RGD:1605727 6480464 Diclofenac affects the expression of FOXA1 mRNA CTD PMID:24752500 dicrotophos increases expression ISO RGD:1605727 6480464 dicrotophos results in increased expression of FOXA1 mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:10718 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOXA1 mRNA CTD PMID:30529165 enzalutamide affects expression ISO RGD:1605727 6480464 enzalutamide affects the expression of FOXA1 mRNA CTD PMID:30940724 epoxiconazole decreases expression ISO RGD:10718 6480464 epoxiconazole results in decreased expression of FOXA1 mRNA CTD PMID:35436446 flusilazole affects expression ISO RGD:10718 6480464 flusilazole affects the expression of FOXA1 mRNA CTD PMID:22634333 folic acid multiple interactions ISO RGD:10718 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXA1 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:10718 6480464 Folic Acid results in decreased expression of FOXA1 mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:1605727 6480464 Fonofos results in increased methylation of FOXA1 promoter CTD PMID:22847954 fulvestrant increases expression ISO RGD:1605727 6480464 Fulvestrant results in increased expression of FOXA1 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO RGD:1605727 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of FOXA1 mRNA], Fulvestrant inhibits the reaction [Estradiol results in decreased expression of FOXA1 mRNA] CTD PMID:31646340 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of FOXA1 mRNA CTD PMID:17785943 hexadecanoic acid multiple interactions ISO RGD:1605727 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of FOXA1 mRNA, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of FOXA1 mRNA CTD PMID:30547786 hydrogen peroxide affects expression ISO RGD:1605727 6480464 Hydrogen Peroxide affects the expression of FOXA1 mRNA CTD PMID:20044591 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of FOXA1 mRNA CTD PMID:20097248 L-methionine multiple interactions ISO RGD:1605727 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FOXA1 mRNA] more ... CTD PMID:25712622 L-methionine multiple interactions ISO RGD:10718 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXA1 gene more ... CTD PMID:20938992 , PMID:25712622 leflunomide decreases expression ISO RGD:1605727 6480464 leflunomide results in decreased expression of FOXA1 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1605727 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of FOXA1 mRNA CTD PMID:35811015 LY294002 multiple interactions ISO RGD:1605727 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in decreased expression of FOXA1 protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FOXA1 mRNA] CTD PMID:25712622 , PMID:26363213 menadione affects expression ISO RGD:1605727 6480464 Vitamin K 3 affects the expression of FOXA1 mRNA CTD PMID:20044591 methylseleninic acid decreases expression ISO RGD:1605727 6480464 methylselenic acid results in decreased expression of FOXA1 mRNA CTD PMID:12517777 , PMID:18548127 mono(2-ethylhexyl) phthalate affects expression ISO RGD:10718 6480464 mono-(2-ethylhexyl)phthalate affects the expression of FOXA1 mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO RGD:10718 6480464 monobutyl phthalate affects the expression of FOXA1 mRNA CTD PMID:21195148 N-methyl-N-nitrosourea decreases expression ISO RGD:1605727 6480464 Methylnitrosourea results in decreased expression of FOXA1 mRNA CTD PMID:27221058 naphthalene increases expression ISO RGD:10718 6480464 naphthalene results in increased expression of FOXA1 protein CTD PMID:16239640 oleic acid multiple interactions ISO RGD:1605727 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of FOXA1 mRNA, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of FOXA1 mRNA CTD PMID:30547786 paracetamol decreases expression ISO RGD:1605727 6480464 Acetaminophen results in decreased expression of FOXA1 mRNA CTD PMID:26690555 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FOXA1 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1605727 6480464 Parathion results in increased methylation of FOXA1 promoter CTD PMID:22847954 perfluorononanoic acid decreases expression ISO RGD:1605727 6480464 perfluoro-n-nonanoic acid results in decreased expression of FOXA1 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO RGD:1605727 6480464 perfluorooctanoic acid results in increased expression of FOXA1 mRNA CTD PMID:25868421 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of FOXA1 mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:10718 6480464 Phenobarbital results in increased expression of FOXA1 mRNA CTD PMID:31836555 pirinixic acid multiple interactions ISO RGD:10718 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FOXA1 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:10718 6480464 pirinixic acid results in decreased expression of FOXA1 mRNA CTD PMID:18445702 , PMID:23811191 potassium dichromate decreases expression ISO RGD:10718 6480464 Potassium Dichromate results in decreased expression of FOXA1 mRNA CTD PMID:23608068 quercetin decreases expression ISO RGD:1605727 6480464 Quercetin results in decreased expression of FOXA1 mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:10718 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FOXA1 mRNA] CTD PMID:25712622 quercetin multiple interactions ISO RGD:1605727 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FOXA1 mRNA] CTD PMID:25712622 reactive oxygen species decreases expression ISO RGD:1605727 6480464 Reactive Oxygen Species results in decreased expression of FOXA1 mRNA CTD PMID:25800948 resveratrol multiple interactions ISO RGD:1605727 6480464 FOXA1 protein promotes the reaction [resveratrol results in increased activity of ESR1 protein], FOXA1 protein promotes the reaction [resveratrol results in increased expression of BMP2 protein] CTD PMID:17513867 resveratrol increases phosphorylation ISO RGD:1605727 6480464 resveratrol results in increased phosphorylation of FOXA1 protein CTD PMID:25311616 rifampicin multiple interactions ISO RGD:1605727 6480464 [Rifampin co-treated with NR1I2 protein] results in decreased expression of FOXA1 mRNA CTD PMID:21127053 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FOXA1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1605727 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of FOXA1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1605727 6480464 4-(5-benzo(1 more ... CTD PMID:31711903 silicon dioxide decreases expression ISO RGD:1605727 6480464 Silicon Dioxide analog results in decreased expression of FOXA1 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:10718 6480464 Silicon Dioxide results in decreased expression of FOXA1 mRNA CTD PMID:23221170 sodium arsenate multiple interactions ISO RGD:1605727 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FOXA1 mRNA CTD PMID:32525701 tamoxifen multiple interactions ISO RGD:1605727 6480464 FOXA1 protein affects the reaction [Tamoxifen affects the activity of ESR1 protein] CTD PMID:21151129 tamoxifen decreases expression ISO RGD:1605727 6480464 Tamoxifen results in decreased expression of FOXA1 mRNA CTD PMID:27089845 temozolomide increases expression ISO RGD:1605727 6480464 Temozolomide results in increased expression of FOXA1 mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1605727 6480464 terbufos results in increased methylation of FOXA1 promoter CTD PMID:22847954 testosterone increases expression ISO RGD:10718 6480464 Testosterone results in increased expression of FOXA1 mRNA CTD PMID:21669218 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FOXA1 mRNA CTD PMID:30723492 tetrachloromethane increases expression ISO RGD:10718 6480464 Carbon Tetrachloride results in increased expression of FOXA1 mRNA CTD PMID:31919559 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of FOXA1 mRNA CTD PMID:24469900 trichostatin A multiple interactions ISO RGD:1605727 6480464 [decitabine co-treated with trichostatin A] results in decreased expression of FOXA1 mRNA CTD PMID:17891453 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of FOXA1 mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1605727 6480464 Troglitazone results in decreased expression of FOXA1 mRNA, Troglitazone results in decreased expression of FOXA1 protein CTD PMID:32822399 troglitazone multiple interactions ISO RGD:1605727 6480464 [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6 more ... CTD PMID:32822399 tunicamycin decreases expression ISO RGD:1605727 6480464 Tunicamycin results in decreased expression of FOXA1 mRNA CTD PMID:29453283 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of FOXA1 mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1605727 6480464 Valproic Acid results in increased methylation of FOXA1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1605727 6480464 Valproic Acid results in increased expression of FOXA1 mRNA CTD PMID:27089845 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of FOXA1 mRNA CTD PMID:19015723 vitamin D decreases expression ISO RGD:10718 6480464 Vitamin D deficiency results in decreased expression of FOXA1 mRNA CTD PMID:32330513 zinc atom multiple interactions ISO RGD:1605727 6480464 [PCI 5002 co-treated with Zinc] results in decreased expression of FOXA1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1605727 6480464 [PCI 5002 co-treated with Zinc] results in decreased expression of FOXA1 mRNA CTD PMID:18593933